Literature DB >> 16027741

Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease.

R A Sweet1, B Devlin, B G Pollock, D L Sukonick, K B Kastango, S-A Bacanu, K V Chowdari, S T DeKosky, R E Ferrell.   

Abstract

Psychotic symptoms in subjects with Alzheimer disease (AD with psychosis, AD+P) define a phenotype characterized by greater cognitive burden than in AD without psychosis. We have proposed that genes of small effect may contribute to the risk for expression of psychosis in multiple disorders, including AD. Recently, sex-differential association of a three-locus haplotype, including a G-->A transition at codon 108/158 of catechol-O-methyltransferase (COMT) resulting in a Val-->Met substitution, has been reported to confer an increased risk for schizophrenia. The main objective of the study was to determine if COMT genetic variation is associated with risk of psychosis in AD, and included a case-control study of 373 individuals diagnosed with AD with, or without, psychosis. All subjects were characterized for alleles at the three loci associated with schizophrenia, RS737865, COMT G-->A 108/158 (RS4680), and RS165599, and for a C/T transition adjacent to an estrogen response element (ERE6) in the COMT P2 promoter region. Both single locus and haplotype tests of association were conducted. Logit models were used to examine independent and interacting effects of alleles at the associated loci. All analyses were stratified by sex. In female subjects, RS4680 demonstrated a modest association with AD+P; RS737865 demonstrated a trend towards an association. There was a highly significant association of AD+P with the four-locus haplotype, which resulted from additive effects of alleles at RS4680 and ERE6 (or RS737865, as this locus was in almost absolute linkage disequilibrium (LD) with ERE6). In male subjects, no single locus test was significant, but there remained a strong association between AD+P and the four-locus haplotype. This association appeared to result from interaction of the ERE6/RS737865, RS4680, and RS165599 loci. Genetic variation in COMT is associated with AD+P, and thus appears to contribute to psychosis risk across disorders. Sex-differential associations of COMT with psychosis may result from variation at, or in LD with, ERE6. Examination of variation at ERE6 in subjects with schizophrenia, and further examination of the independent and additive effects of variations in COMT on gene expression, is warranted.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16027741     DOI: 10.1038/sj.mp.4001709

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  22 in total

Review 1.  Genetics of psychosis of Alzheimer disease.

Authors:  Chintan Shah; Mary Ann A DeMichele-Sweet; Robert A Sweet
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-01-12       Impact factor: 3.568

2.  Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association.

Authors:  Chang-En Yu; Howard Seltman; Elaine R Peskind; Nichole Galloway; Peter X Zhou; Elisabeth Rosenthal; Ellen M Wijsman; Debby W Tsuang; Bernie Devlin; Gerard D Schellenberg
Journal:  Genomics       Date:  2007-04-16       Impact factor: 5.736

3.  Genetic variation in the alpha 7 nicotinic acetylcholine receptor is associated with delusional symptoms in Alzheimer's disease.

Authors:  Robyn Carson; David Craig; Dominic Hart; Stephen Todd; Bernadette McGuinness; Janet A Johnston; Francis A O'Neill; Craig W Ritchie; A Peter Passmore
Journal:  Neuromolecular Med       Date:  2008-08-12       Impact factor: 3.843

Review 4.  Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links.

Authors:  D K Sokol; B Maloney; J M Long; B Ray; D K Lahiri
Journal:  Neurology       Date:  2011-04-12       Impact factor: 9.910

5.  Clitoria ternatea ameliorated the intracerebroventricularly injected streptozotocin induced cognitive impairment in rats: behavioral and biochemical evidence.

Authors:  Jogender Mehla; Monika Pahuja; Pooja Gupta; Shekhar Dethe; Amit Agarwal; Yogendra Kumar Gupta
Journal:  Psychopharmacology (Berl)       Date:  2013-07-06       Impact factor: 4.530

Review 6.  Genetics of psychosis in Alzheimer's disease: a review.

Authors:  Mary Ann DeMichele-Sweet; Robert A Sweet
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 7.  Treatment of cognitive deficits associated with schizophrenia: potential role of catechol-O-methyltransferase inhibitors.

Authors:  José A Apud; Daniel R Weinberger
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

8.  The relationship of excess cognitive impairment in MCI and early Alzheimer's disease to the subsequent emergence of psychosis.

Authors:  Elise A Weamer; James E Emanuel; Daniel Varon; Sachiko Miyahara; Patricia A Wilkosz; Oscar L Lopez; Steven T Dekosky; Robert A Sweet
Journal:  Int Psychogeriatr       Date:  2008-09-25       Impact factor: 3.878

Review 9.  Sex steroid-related candidate genes in psychiatric disorders.

Authors:  Lars Westberg; Elias Eriksson
Journal:  J Psychiatry Neurosci       Date:  2008-07       Impact factor: 6.186

10.  The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers.

Authors:  Manuel Fernández Martínez; Xabier Elcoroaristizabal Martín; Luís Galdos Alcelay; Jessica Castro Flores; Juan María Uterga Valiente; Begoña Indakoetxea Juanbeltz; María Angeles Gómez Beldarraín; Josefa Moraza López; María Carmen Gonzalez-Fernández; Ana Molano Salazar; Rocio Bereincua Gandarias; Sandra Inglés Borda; Nuria Ortiz Marqués; Miryam Barandiarán Amillano; María Carrasco Zabaleta; Marian M de Pancorbo
Journal:  BMC Neurosci       Date:  2009-09-30       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.